Ludwig Enterprises (LUDG) EBT Margin (2024)
Ludwig Enterprises posted quarterly EBT Margin of 361898.07% for Q3 2024, up 97.71% on a QoQ basis from 15783440.0% in Q1 2024.
Ludwig Enterprises (LUDG) has 1 years of EBT Margin data on file, last reported at 361898.07% in Q3 2024.
- For the quarter ending Q3 2024, EBT Margin changed N/A year-over-year to 361898.07%; the trailing twelve-month figure through Dec 2024 stood at 1406307.37% (changed N/A YoY), and the FY2024 full-year result was 1406307.37%, changed N/A from the prior year.
- EBT Margin for Q3 2024 stood at 361898.07%, up from 15783440.0% in the prior quarter.
- Across five years, EBT Margin topped out at 361898.07% in Q3 2024 and bottomed at 15783440.0% in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Ludwig Enterprises | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -361,898.07% |
| Mar 31, 2024 | -15,783,440.00% |